Online Only Articles

Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib

Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Cytogenetics, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN;Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA
Vol. 104 No. 5 (2019): May, 2019 https://doi.org/10.3324/haematol.2018.215103